Affiliation: Cairo University
- Mental health in EgyptAhmed Okasha
WHO Collaborating Center for Training and Research, Institute of Psychiatry, Ain Shams University, Kasr El Nil, Cairo, Egypt
Isr J Psychiatry Relat Sci 42:116-25. 2005..The psychiatric services for children are in their infancy. Since 1983 the common and semi-accepted use of hashish has been joined by abuse by heroin and other substances...
- Sleep EEG findings in ICD-10 borderline personality disorder in EgyptTarek Asaad
Ain Shams University, Institute of Psychiatry, 3 Shawarby St Kasr El Nile, Cairo, Egypt
J Affect Disord 71:11-8. 2002..This study aimed at investigating such a hypothesis in an Egyptian sample, considering the possible influence of cultural differences...
- Introduction to the forum: Is cannabis consumption a lifestyle or brain disease?Ahmed Okasha
Institute of Psychiatry, Ain Shams University, Kasr El Nil, Cairo, Egypt
Curr Opin Psychiatry 21:114-5. 2008
- A psychiatric study of nonorganic chronic headache patientsA Okasha
Institute of Psychiatry, Faculty of Medicine, Ain Shams University, Cairo, Egypt
Psychosomatics 40:233-8. 1999....
- Mental health and violence: WPA Cairo declaration--international perspectives for interventionA Okasha
WHO Collaborating Center for Research and Training in Mental Health Institute of Psychiatry, Ain Shams University, Cairo, Egypt
Int Rev Psychiatry 19:193-200. 2007....
- Would the use of dimensions instead of categories remove problems related to subthreshold disorders?Ahmed Okasha
Institute of Psychiatry, Ain Shams University, Cairo 3 Shawarby Street, Kasr El Nil, Cairo, Egypt
Eur Arch Psychiatry Clin Neurosci 259:S129-33. 2009....
- Mental health in the Middle East: an Egyptian perspectiveA Okasha
Institute of Psychiatry, Ain Shams University, Cairo, Egypt
Clin Psychol Rev 19:917-33. 1999..An outline of psychiatric disorders in children is discussed. The problem of drug abuse is also addressed, especially that in Egypt after 1983, where drugs like heroine replaced the common habit of hashish...
- Prodromal symptoms of relapse in a sample of Egyptian schizophrenic patientsA Okasha
Institute of Psychiatry, Ain Shams University, Cairo, Egypt
J Clin Psychiatry 61:729-36. 2000..The aim of this study was to determine if prodromal symptoms could be used as valid predictors of relapse in schizophrenic disorders and the relative diagnostic values of these symptoms in a sample of Egyptian schizophrenic patients...
- Egyptian contribution to the concept of mental healthA Okasha
WHO Collaborating Centre for Research and Training in Mental Health, Institute of Psychiatry, Ain Shams University, Cairo, Egypt
East Mediterr Health J 7:377-80. 2001..This paper provides an historical look at the Egyptian contribution to mental health from Pharaonic times through to the Islamic era and up to today. The current situation as regards mental health in Egypt is described...
- Prevalence of obsessive compulsive symptoms (OCS) in a sample of Egyptian adolescentsA Okasha
WHO Collaborating Center, Institute of Psychiatry, Faculty of Medicine, Ain Shams University, Cairo, Egypt
Encephale 27:8-14. 2001..Aggressive, contamination and religious obsessions and cleaning compulsions were the commonest among the sample; 19.6% of subjects with OCS fulfilled ICD-10 criteria for OCD...
- Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statementHans Jurgen Moller
Department of Psychiatry, Ludwig Maximilians University Munchen, Nussbaumstrasse 7, 80336 Munich, Germany
Eur Arch Psychiatry Clin Neurosci 258:3-23. 2008..It is the major problem facing efforts to identify the possible 'suicidal effects' of antidepressants...
- [World Psychiatry Association: Madrid Declaration of ethical principles in psychiatric practice]Ahmed Okasha
Psychiatr Hung 21:256-61. 2006
- Psychiatry and political-institutional abuse from the historical perspective: the ethical lessons of the Nuremberg Trial on their 60th anniversaryFrancisco López-Muñoz
Neuropsychopharmacology Unit, Pharmacology Department, University of Alcala, Madrid, Spain
Prog Neuropsychopharmacol Biol Psychiatry 31:791-806. 2007..Various strategies can be used to combat such abuses, though it is uncertain how effective they are in preventing them...
- Psychiatric research in an international perspective. The role of WPAAhmed Okasha
Acta Psychiatr Scand 107:81-4. 2003
- WCA recommendations for the long-term treatment of generalized anxiety disorderChrister Allgulander
Department of Psychiatry, Harvard University School of Medicine, Boston, Massachusetts, USA
CNS Spectr 8:53-61. 2003..Treatment gains after a 12-week course of CBT may be maintained for up to 1 year. Currently, no guidelines exist for the long-term treatment of GAD...
- WCA recommendations for the long-term treatment of social phobiaMichael Van Ameringen
Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, Ontario, Canada
CNS Spectr 8:40-52. 2003..In light of the chronicity and disability associated with social phobia, as well as the high relapse rate after short-term therapy, it is recommended that effective treatment be continued for at least 12 months...
- WCA recommendations for the long-term treatment of panic disorderMark H Pollack
Division of Psychiatry, Huddinge University Hospital, Stockholm, Sweden
CNS Spectr 8:17-30. 2003..Long-term efficacy and ease of use are important considerations in treatment selection, as maintenance treatment is recommended for at least 12-24 months, and in some cases, indefinitely...
- WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adultsJohn H Greist
Healthcare Technology Systems, Inc, Madison, Wisconsin 53717, USA
CNS Spectr 8:7-16. 2003..Further, pharmacotherapy for a minimum of 1-2 years is recommended before very gradual withdrawal may be considered...
- WCA Recommendations for the long-term treatment of posttraumatic stress disorderDan J Stein
Medical Research Council Research Unit on Anxiety Disorder, University of Stellenbosch, Cape Town, Tygerberg, South Africa
CNS Spectr 8:31-9. 2003..Only SSRIs have been proven effective and safe in long-term randomized controlled trials. Current guidelines from the Expert Consensus Panel for PTSD recommend treatment of chronic PTSD for a minimum of 12-24 months...